Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

by palligoelme@gmail.com | Dec 31, 2025 | Clinical Trials

​ Conditions: Breast Cancer Survivor; Colorectal Cancer Survivors Interventions: Behavioral: virtual self-management intervention Sponsors: Nova Scotia Health Authority; Canadian Cancer Society (CCS) Not yet recruiting Conditions: Breast Cancer Survivor; Colorectal...

The Extended Study of Prevalence of Infection in Intensive Care IV

by palligoelme@gmail.com | Dec 30, 2025 | Clinical Trials

​ Conditions: Sepsis; Infection Sponsors: Universidad de la Sabana; St. James’s Hospital, Ireland Not yet recruiting Conditions: Sepsis; Infection Sponsors: Universidad de la Sabana; St. James’s Hospital, Ireland Not yet...

Alginate vs Sucralfate for GERD Symptomatic Relief

by palligoelme@gmail.com | Dec 30, 2025 | Clinical Trials

​ Conditions: GERD Interventions: Drug: ALGINATE; Drug: Sucralfate Sponsors: CMH Lahore Medical College and Institute of Dentistry Recruiting Conditions: GERD Interventions: Drug: ALGINATE; Drug: Sucralfate Sponsors: CMH Lahore Medical College and Institute of...

Yoga With and Without VR for Core, Balance, and Stress in University Students

by palligoelme@gmail.com | Dec 30, 2025 | Clinical Trials

​ Conditions: Health-Related Behavior Interventions: Other: Yoga; Other: Virtual Reality Sponsors: Istinye University Recruiting Conditions: Health-Related Behavior Interventions: Other: Yoga; Other: Virtual Reality Sponsors: Istinye University...

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

by palligoelme@gmail.com | Dec 30, 2025 | Clinical Trials

​ Conditions: Advanced Lung Cancer Interventions: Drug: JS212 for Injection; Drug: JS207 for Injection; Drug: Toripalimab; Drug: JS213 for Injection Sponsors: Shanghai Junshi Bioscience Co., Ltd. Not yet recruiting Conditions: Advanced Lung Cancer Interventions: Drug:...

An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors

by palligoelme@gmail.com | Dec 29, 2025 | Clinical Trials

​ Conditions: Advanced Malignant Solid Tumor Interventions: Drug: RPTR-1-201; Drug: PD-1 / PD-L1 monoclonal antibody Sponsors: Repertoire Immune Medicines Not yet recruiting Conditions: Advanced Malignant Solid Tumor Interventions: Drug: RPTR-1-201; Drug: PD-1 / PD-L1...